Row

a. H5N1Giza challenge, AnhuiVACC, I

b. H5N1Giza challenge, AnhuiVACC, II

c. H5N1Giza challenge, AnhuiVACC, III

d. H5N1Giza challenge, AnhuiVACC, IV

e. H5N1Giza challenge, AnhuiVACC, V

f. H5N1Giza challenge, AnhuiVACC, VI

Row

g. H5N1Giza challenge, AC-AnhuiVACC, I

h. H5N1Giza challenge, AC-AnhuiVACC, II

i. H5N1Giza challenge, AC-AnhuiVACC, III

j. H5N1Giza challenge, AC-AnhuiVACC, IV

k. H5N1Giza challenge, AC-AnhuiVACC, V

l. H5N1Giza challenge, AC-AnhuiVACC, VI

Row

m. H5N1Giza challenge, GizaVACC, I

n. H5N1Giza challenge, GizaVACC, II

o. H5N1Giza challenge, GizaVACC, III

p. H5N1Giza challenge, GizaVACC, IV

q. H5N1Giza challenge, GizaVACC, V

r. H5N1Giza challenge, GizaVACC, VI

Row

Supplementary Data 9 | Individual antibody profiles of animals from the H5N1Giza vaccination-challenge study.  
Individual immune responses upon vaccination with A(H5N6) split-inactivated vaccines in the H5N1Giza challenge study. Individual animal data used to generate mean antibody profiles displayed in Fig. 3 and Supplementary Data 8. For each HA vaccine antigen, the position, breadth and height of individual sera are represented in the antigenic map from Supplementary Data 5b. HA antigen present in vaccine: (a-f) AnhuiVACC, (g-l) AC-AnhuiVACC and (m-r) GizaVACC. Using the same representation as Supplementary Data 6.